To go where no one has gone before: Drugging the Undruggable

Dr. Diane Jorkasky is a 23 year veteran of the pharmaceutical industry with experience in Phase 1 through Phase 4. She is currently head of development and chief medical officer at Aileron Therapeutics in Cambridge, Massachusetts, where she is involved in the development of stapled peptides. Prior to this appointment she had been vice president of Global Clinical Research Operations, its clinical research units and leader of the Operational Excellence Board for Development at the Pfizer Global Research and Development New London, Connecticut. 

In this role, Dr. Jorkasky was responsible for ensuring that all exploratory development, clinical pharmacology (phase 1-4), translational medicine and clinical technology studies were conducted and reported. She led the complete alignment of the three Pfizer Clinical Research Units, located in the US, Europe and Asia, such that they operated as one clinical unit and were recently awarded certification by American Accreditation for Human Rights Protection Policies for their clinical research process, the first in industry to achieve such a recognition.

Dr. Jorkasky is board certified in internal medicine, nephrology and clinical pharmacology. She is on the faculties of Yale, Penn and Uniformed Service of Health Sciences Medical Schools. She has published on over 100 peer review articles. Most recently Dr. Jorkasky was selected to be a Woodrow Wilson visiting fellow.

Lunch will be provided.